Denali Therapeutics Balance Sheet (2017-2026) | DNLI

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	485.68M	394.55M	293.48M	104.95M	155.09M	118.61M	218.04M	68.13M	131.97M	148.01M	127.11M	60.57M	74.68M	90.64M	174.96M	56.95M	141.21M	90.96M	205.33M	387.63M
Receivables - Net (Quarter)	15.22M							3.20M	3.40M	2.10M	3.42M	1.90M	1.40M	1.40M	1.50M	1.70M	1.40M	1.90M	1.60M	1.60M
Receivables - Other (Quarter)	1.57M	1.19M	1.23M		0.36M
Receivables (Quarter)	16.79M	1.19M	1.23M		0.36M			3.20M	3.40M	2.10M	3.42M	1.90M	1.40M	1.40M	1.50M	1.70M	1.40M	1.90M	1.60M	1.60M
Prepaid Assets (Quarter)	16.03M	15.14M	30.60M	30.91M	45.58M	32.47M	36.10M	36.71M	33.08M	33.63M	29.63M	36.71M	32.34M	32.28M	32.10M	60.71M	35.75M	34.39M	32.78M	35.07M
Current Assets (Quarter)	1,341.74M	1,055.51M	897.23M	988.44M	1,114.60M	1,138.53M	1,372.32M	1,325.16M	1,224.06M	1,142.88M	1,064.14M	973.58M	928.38M	868.84M	864.44M	878.64M	934.71M	882.60M	900.66M	1,022.75M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	40.35M	40.01M	38.87M	37.68M	38.70M	41.69M	44.09M	42.12M	39.82M	48.10M	45.59M	46.86M	48.08M	50.82M	55.24M	57.77M	58.72M	53.73M	52.40M	51.73M
Long-Term Investments (Quarter)	92.52M	319.47M	425.45M	250.27M	94.22M					7.91M		490.72M	450.99M	445.46M	359.37M	235.84M	78.46M	24.70M	98.32M	63.78M
Intangibles (Quarter)																				36.00M
Goodwill & Intangibles (Quarter)																				36.00M
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)	3.58M	3.78M	11.87M	14.21M	15.18M	16.12M	13.40M	14.02M	14.43M	11.14M	18.14M	44.62M	50.58M	26.49M	24.74M	26.93M	22.97M	25.11M	25.94M	26.22M
Non-Current Assets (Quarter)	168.07M	394.46M	506.93M	332.42M	177.86M	89.08M	87.92M	84.18M	81.67M	93.89M	89.78M	607.52M	574.18M	585.17M	509.74M	392.70M	231.53M	173.02M	244.20M	243.27M
Assets (Quarter)	1,509.82M	1,449.97M	1,404.16M	1,320.86M	1,292.46M	1,227.61M	1,460.24M	1,409.34M	1,305.73M	1,236.78M	1,153.92M	1,581.09M	1,502.57M	1,454.01M	1,374.18M	1,271.34M	1,166.24M	1,055.62M	1,144.85M	1,266.02M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	4.24M	4.82M	4.78M	3.36M	7.12M	7.54M	2.79M	2.21M	7.00M	10.40M	9.48M	11.86M	13.94M	9.59M	11.14M	8.46M	10.84M	6.75M	0.51M	40.38M
Payables (Quarter)	4.24M	4.82M	4.78M	3.36M	7.12M	7.54M	2.79M	2.21M	7.00M	10.40M	9.48M	11.86M	13.94M	9.59M	11.14M	8.46M	10.84M	6.75M	0.51M	40.38M
Accumulated Expenses (Quarter)	6.29M	10.53M	19.01M	5.84M	8.31M	13.25M	66.69M	7.37M	10.26M	16.34M	68.50M	5.99M	9.55M	4.83M	91.07M	7.35M	12.07M	4.94M	97.85M	69.78M
Other Accumulated Expenses (Quarter)			53.16M				4.39M
Short term Debt (Quarter)				2.71M		1.44M	4.39M
Current Leases (Quarter)	5.05M	5.25M	5.45M	5.66M	5.87M	7.07M	7.32M	6.54M	6.77M	7.01M	7.26M	7.51M	7.77M	8.04M	8.31M	8.59M	8.87M	9.16M
Current Deferred Revenue (Quarter)	5.75M	1.32M	27.91M			0.02M	290.05M	288.90M	1.30M
Total Current Liabilities (Quarter)	51.41M	54.25M	378.25M	341.24M	348.16M	360.67M	363.92M	391.08M	69.36M	71.18M	77.98M	82.58M	74.53M	87.09M	102.21M	91.88M	91.06M	90.15M	98.35M	110.16M
Non-Current Liabilities
Capital Leases (Quarter)														5.63M	5.62M	5.60M	5.58M	5.55M	5.53M	5.51M
Non-Current Deffered Revenue (Quarter)	31.31M	31.31M	3.40M	3.40M	3.40M		0.48M
Operating Leases (Quarter)	61.40M	65.24M	58.55M	62.74M	61.40M	54.98M	53.03M	50.55M	48.75M	46.89M	44.98M	50.55M	48.75M	38.85M	36.67M	43.03M	32.11M	29.69M	27.21M	24.68M
Other Non-Current Liabilities (Quarter)	0.70M	0.70M	0.38M	0.38M	0.38M	0.38M	0.38M	0.38M	0.38M	0.38M
Total Non-Current Liabilities (Quarter)	436.41M	436.99M	441.49M	402.55M	407.63M	415.92M	417.43M	442.26M	118.53M	118.07M	122.96M
Total Liabilities (Quarter)	437.11M	437.69M	441.87M	402.93M	408.01M	416.30M	417.81M	442.64M	118.91M	118.45M	122.96M	125.62M	115.51M	135.52M	144.50M	148.66M	139.19M	129.42M	131.09M	339.93M
Shareholder's Equity
Total Debt (Quarter)				2.71M		1.44M	4.39M
Common Equity (Quarter)	1,072.70M	1,012.28M	962.29M	917.93M	884.45M	811.30M	1,042.43M	966.71M	1,186.83M	1,118.33M	1,030.95M	1,455.47M	1,387.05M	1,318.49M	1,229.68M	1,122.69M	1,027.05M	926.20M	1,013.76M	926.10M
Shareholder's Equity (Quarter)	1,072.70M	1,012.28M	962.29M	917.93M	884.45M	811.30M	1,042.43M	966.71M	1,186.83M	1,118.33M	1,030.95M	1,455.47M	1,387.05M	1,318.49M	1,229.68M	1,122.69M	1,027.05M	926.20M	1,013.76M	926.10M
Liabilities and Shareholders Equity (Quarter)	1,509.82M	1,449.97M	1,404.16M	1,320.86M	1,292.46M	1,227.61M	1,460.24M	1,409.34M	1,305.73M	1,236.78M	1,153.92M	1,581.09M	1,502.57M	1,454.01M	1,374.18M	1,271.34M	1,166.24M	1,055.62M	1,144.85M	1,266.02M
Retained Earnings (Quarter)	-0.37M	-0.52M	-2.50M	-710.22M	-769.01M	-872.31M	-6.89M	-1080.77M	-897.38M	-996.74M	-1116.21M	-1.30M	-2.66M	-1424.23M	-1538.98M	2.04M	0.94M	1.10M	-2051.52M	-0.68M
Treasury Shares (Quarter)	2.65M	2.62M	2.63M	2.95M	2.90M	3.36M	3.33M	3.95M	3.86M	3.72M	3.64M	4.30M	4.15M	3.99M	4.13M	4.85M	5.13M	5.18M	5.12M	6.88M
Shares Outstanding (Quarter)	121.53M	122.01M	122.28M	122.86M	123.16M	123.80M	135.97M	136.74M	137.36M	138.05M	138.39M	142.51M	143.12M	143.84M	144.22M	145.25M	145.69M	146.63M	156.18M	158.66M

Research Tools

Denali Therapeutics Balance Sheet (2017-2026) | DNLI

Create an account

Sign In

Reset Password